CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: BIO 2016 (619) Pharma Startups (6570)
HemoShear Therapeutics discovers novel biological targets and advances drug programs to treat metabolic disorders with significant unmet patient need. Its proprietary drug discovery platform, REVEAL-TX, enables the company to create best-in-class, bi...Show all
Company (Alive / Active)
Phone: 434-872-0196
501 Locust Avenue
Suite 301
Charlottesville, 22902
Virginia, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| HemoShear Therapeutics | $23.4M | Aug 14, 2018 |
| See all 13 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|---|---|---|
| Undisclosed Angel Investors | Angel Investor (Individual) | Series C - II, Seed | |
| National Heart Lung and Blood Institute | Government | Bethesda, Maryland, United States | Grant - II, Grant |
| CIT GAP Funds | Venture Capital | Herndon, Virginia, United States | Other Investors |
| National Institutes of Health | Government | Bethesda, Maryland, United States | Grant - II, Grant |
| National Organization for Rare Disorders | Non-Profit Foundation | Danbury, Connecticut, United States | Grant - III |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| In vitro model for pathological or physiologic conditions | Apr 18, 2013 | May 23, 2017 | Patent |
| In vitro model for a tumor microenvironment | Oct 21, 2014 | Apr 11, 2017 | Patent |
| In vitro model for pathological or physiologic conditions | Apr 18, 2013 | Nov 22, 2016 | Patent |
| Use of an in vitro hemodynamic endothelial/smooth muscle cell co-culture model to identify new therapeutic targets for vascular disease | Oct 11, 2010 | Oct 28, 2014 | Patent |
| Use of an in vitro hemodynamic endothelial/smooth muscle cell co-culture model to identify new therapeutic targets for vascular disease | Jan 10, 2008 | Oct 12, 2010 | Patent |
